Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Shanghai Pulmonary Hospital, Shanghai, China
Study on the tumor immune escape in advanced non-small cell lung cancer patients with EGFR and ALK mutant negative by NGS combined with RNAseq. Detecting non-small cell lung cancer patient NGS and RNAseq data before first-line chemotherapy, after two cycles chemotherapy and after disease progression.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Non-small cell lung cancer patient First-line chemotherapy with platinum-based chemotherapy
